PsA: IL17 Inhibition

IL-17 Inhibition in Spondyloarthritis: A Targeted Approach in Psoriatic Arthritis

Prof Philip Mease introduced psoriatic arthritis (PsA) with a particular emphasis on disease symptoms and an update on the status of current disease management.

PsA Structural Damage Inhibited with Secukinumab

Loading dose appears to improve outcomes, researchers say